Pengfei Liu
- Cancer Research top 10%
- Molecular Biology top 10%
- RNA modifications and cancer 10
- ATP Synthase and ATPases Research 5
- Cancer-related gene regulation 5
- PI3K/AKT/mTOR signaling in cancer 4
- Ubiquitin and proteasome pathways 4
- Oncology top 10%
- Cancer Cells and Metastasis 4
-
- Fungal Plant Pathogen Control 7
-
- Lung Cancer Treatments and Mutations 4
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Pengfei Liu
74 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 236
- Molecular Biology 722
- Oncology 242
- Immunology 145
- Genetics 72
Countries citing papers authored by Pengfei Liu
This map shows the geographic impact of Pengfei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Liu more than expected).
Fields of papers citing papers by Pengfei Liu
This network shows the impact of papers produced by Pengfei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Liu. The network helps show where Pengfei Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pengfei Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 14 | |
| 5 | 2021 | 10 | |
| 6 | 2020 | 5 | |
| 7 | 2019 | 11 | |
| 8 | 2018 | 11 | |
| 9 | 2017 | 17 | |
| 10 | 2016 | 22 | |
| 11 | 2016 | 38 | |
| 12 | 2015 | 22 | |
| 13 | Relationship of D-dimer with the prognosis of non-Hodgkin's lymphoma | 2013 | 0 |
| 14 | 2013 | 35 | |
| 15 | 2013 | 20 | |
| 16 | 2013 | 96 | |
| 17 | 2012 | 4 | |
| 18 | 2012 | 38 | |
| 19 | 2011 | 18 | |
| 20 | Significance of preventive TACE in primary liver cancer after operation | 2005 | 2 |
About Pengfei Liu
Pengfei Liu is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 79 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Fungal Plant Pathogen Control (7 papers), ATP Synthase and ATPases Research (5 papers), Cancer-related gene regulation (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Ubiquitin and proteasome pathways (4 papers), Cancer Cells and Metastasis (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Cancer Research (236 citations), Molecular Biology (722 citations) and Oncology (242 citations). Pengfei Liu has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Ruihua Shi, Yi Gao, Weidong Shen, Shuyu Zhang, Jundong Zhou, Jianping Cao, Xiaoping Zou, Yulai Zhou, Duanqing Pei and Yanmei Zhang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.